1. Home
  2. CHEB vs TSVT Comparison

CHEB vs TSVT Comparison

Compare CHEB & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEB
  • TSVT
  • Stock Information
  • Founded
  • CHEB 2024
  • TSVT 2021
  • Country
  • CHEB Singapore
  • TSVT United States
  • Employees
  • CHEB N/A
  • TSVT N/A
  • Industry
  • CHEB
  • TSVT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHEB
  • TSVT Health Care
  • Exchange
  • CHEB NYSE
  • TSVT Nasdaq
  • Market Cap
  • CHEB 120.0M
  • TSVT 128.5M
  • IPO Year
  • CHEB 2024
  • TSVT N/A
  • Fundamental
  • Price
  • CHEB $10.18
  • TSVT $2.61
  • Analyst Decision
  • CHEB
  • TSVT Buy
  • Analyst Count
  • CHEB 0
  • TSVT 4
  • Target Price
  • CHEB N/A
  • TSVT $8.50
  • AVG Volume (30 Days)
  • CHEB 11.4K
  • TSVT 278.0K
  • Earning Date
  • CHEB 01-01-0001
  • TSVT 03-04-2025
  • Dividend Yield
  • CHEB N/A
  • TSVT N/A
  • EPS Growth
  • CHEB N/A
  • TSVT N/A
  • EPS
  • CHEB N/A
  • TSVT N/A
  • Revenue
  • CHEB N/A
  • TSVT $45,620,000.00
  • Revenue This Year
  • CHEB N/A
  • TSVT N/A
  • Revenue Next Year
  • CHEB N/A
  • TSVT $37.70
  • P/E Ratio
  • CHEB N/A
  • TSVT N/A
  • Revenue Growth
  • CHEB N/A
  • TSVT N/A
  • 52 Week Low
  • CHEB $9.96
  • TSVT $2.29
  • 52 Week High
  • CHEB $26.25
  • TSVT $6.00
  • Technical
  • Relative Strength Index (RSI)
  • CHEB N/A
  • TSVT 50.02
  • Support Level
  • CHEB N/A
  • TSVT $2.38
  • Resistance Level
  • CHEB N/A
  • TSVT $2.82
  • Average True Range (ATR)
  • CHEB 0.00
  • TSVT 0.18
  • MACD
  • CHEB 0.00
  • TSVT 0.04
  • Stochastic Oscillator
  • CHEB 0.00
  • TSVT 58.18

About CHEB CHENGHE ACQUISITION II CO

Chenghe Acquisition II Co is a blank check company.

About TSVT 2seventy bio Inc.

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Share on Social Networks: